Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
441.62
657.11
510.95
534.73
589.77
652.56
511.56
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
441.62
657.11
510.95
534.73
589.77
652.56
511.56
Raw Material Cost
322.69
402.29
370.33
360.92
302.23
325.04
301.98
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
99.75
92.88
85.92
73.48
71.78
65.78
57.49
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.53
0.58
0.57
0.37
2.51
4.27
6.94
Selling and Distribution Expenses
58.27
59.05
46.78
37.98
65.29
88.20
78.58
Other Expenses
-6.87
-4.30
-6.78
-5.66
-5.21
-4.58
-4.42
Total Expenditure (Excl Depreciation)
412.51
511.82
435.81
416.16
389.67
437.49
400.80
Operating Profit (PBDIT) excl Other Income
29.1
145.29999999999998
75.1
118.6
200.10000000000002
215.10000000000002
110.8
Other Income
55.50
56.62
73.53
20.29
1.04
7.63
2.81
Operating Profit (PBDIT)
112.09
223.71
170.43
158.22
219.33
244.46
129.61
Interest
0.53
0.58
0.57
0.37
2.51
4.27
6.94
Exceptional Items
14.58
1.44
-0.66
0.70
0.00
-1.44
0.00
Gross Profit (PBDT)
118.93
254.82
140.62
173.81
287.54
327.52
209.58
Depreciation
25.72
21.76
21.76
19.37
18.19
21.76
16.05
Profit Before Tax
100.42
202.82
147.44
139.18
198.63
217.00
106.62
Tax
8.87
26.70
21.65
17.54
30.56
32.38
15.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
91.55
176.12
125.79
121.65
168.07
100.29
47.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
91.55
176.12
125.79
121.65
168.07
100.29
47.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
84.33
43.74
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
91.55
176.12
125.79
121.65
168.07
184.62
91.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
0.0
0.0
0.0
Reserves
2,309.69
2,356.68
2,276.57
2,222.78
700.39
488.25
286.09
Earnings per share (EPS)
0.22
0.42
0.3
0.29
0.4
0.24
0.11
Diluted Earnings per share
0.22
0.42
0.3
0.29
0.4
0.24
0.11
Operating Profit Margin (Excl OI)
6.99%
22.12%
14.71%
22.17%
33.93%
32.96%
21.65%
Gross Profit Margin
28.56%
34.18%
33.12%
29.65%
36.76%
36.59%
23.98%
PAT Margin
20.73%
26.8%
24.62%
22.75%
28.5%
15.37%
9.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -32.80% vs 28.59% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -48.04% vs 39.98% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -66.13% vs 72.45% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -16.67% vs 0.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Hubei Biocause Heilen Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
441.62
0
441.62
Other Operating Income
0.00
0.00
0.00
Total Operating income
441.62
0
441.62
Raw Material Cost
322.69
0
322.69
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
99.75
0
99.75
Power Cost
0
0
0.00
Manufacturing Expenses
0.53
0
0.53
Selling and Distribution Expenses
58.27
0
58.27
Other Expenses
-6.87
0.00
-6.87
Total Expenditure (Excl Depreciation)
412.51
0
412.51
Operating Profit (PBDIT) excl Other Income
29.11
0.00
29.11
Other Income
55.50
0
55.50
Operating Profit (PBDIT)
112.09
0
112.09
Interest
0.53
0
0.53
Exceptional Items
14.58
0
14.58
Gross Profit (PBDT)
118.93
0
118.93
Depreciation
25.72
0
25.72
Profit Before Tax
100.42
0
100.42
Tax
8.87
0
8.87
Provisions and contingencies
0
0
0.00
Profit After Tax
91.55
0
91.55
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
91.55
0
91.55
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
91.55
0
91.55
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,309.69
0
2,309.69
Earnings per share (EPS)
0.22
0
0.22
Diluted Earnings per share
0.22
0
0.22
Operating Profit Margin (Excl OI)
6.99%
0%
0.00
6.99%
Gross Profit Margin
28.56%
0%
0.00
28.56%
PAT Margin
20.73%
0%
0.00
20.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 44.16 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -32.80% vs 28.59% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 9.15 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -48.04% vs 39.98% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.66 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -66.13% vs 72.45% in Dec 2023
Annual - Interest
Interest 0.05 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -16.67% vs 0.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.99%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
